To the Editor

1
In allergen-sensitized asthmatic individuals, allergen-specific type-2 T-helper (Th2) cells for asthma exacerbations. Of interest, many asthma susceptibility genes are expressed in the 7 airway epithelium [1] , which forms the first continuous line of defense against inhaled 8 environmental insults, including viruses and aeroallergens. Impaired immune regulation and 9 failure to maintain tolerance to allergens is thought to contribute to allergic sensitization. Asthma 10 epithelium may be deficient in its innate immune defense against virus infections, resulting in 11 increased viral replication upon rhinovirus infection compared to non-asthma-derived epithelial 12 cultures [2] . Furthermore, there is evidence for loss of the mucosal immune barrier in asthma,
13
with disruption of epithelial integrity [1, 3] . This may not only lead to increased permeability, but 14 also result in the release of pro-inflammatory mediators, specifically of cytokines that drive type-15 2 responses[3,4]. We recently observed that the ability of allergens to disrupt epithelial barrier 16 function is related to the development of type-2-mediated inflammation in asthma [5, 6] .
17
Furthermore, we demonstrated that healthy murine lung epithelium is a potent inhibitor of T cell 18 proliferation and that this inhibition is lost upon viral infection [7] . It is unknown if this immune 19 regulatory effect is displayed by human epithelium and is dysregulated in asthma. We were used (see fig. 1E for further characteristics). The study was approved by the Medical Ethics
4
Committee of the UMCG. All subjects gave their written informed consent. PBECs were 5 cultured in hormonally-supplemented bronchial epithelium growth medium (BEGM, Lonza) as 6 described before [8] [9] [10] . PBECs were seeded in 12-well plates, grown to ~90% confluence, 1D ).
14 PBECs cultured alone did not secrete detectable levels of any of these cytokines.
15
To study whether airway epithelium in asthma is deficient in its immunosuppressive 16 capacity, we compared the effect of PBECs from asthma patients and healthy controls ( fig. 1E ).
17
Both asthma-derived and control-derived PBECS formed confluent cell monolayer, without 18 morphological differences as observed by microscopy, and both markedly inhibited T cell 19 proliferation ( fig. 1F ). However, asthma-derived PBECs were significantly less potent in doing 20 so ( fig. 1F ). Furthermore, PBECs from both asthmatics and healthy controls had a similar 21 capacity to inhibit type-2 cytokine production, as shown for IL-13 ( fig. 1G ), without significant 22 differences between the subject groups.
23
We previously showed that regulatory effect of healthy murine epithelial cells was lost 1 upon viral infection [7] . Respiratory RNA viruses act on Toll-like receptor (TLR)3, potentially 2 mediating airway inflammation in virus-induced asthma exacerbations [11, 12] . Therefore, we Together, our data suggest that asthma and viral infection compromise the 9 immunosuppressive capacity of airway epithelium, which may be most impaired during virus-10 induced exacerbations of asthma, resulting in severe inflammation and a loss of asthma control.
11
Such a major compromise of epithelial immune suppressive capacity was not found and not 12 expected in the epithelium from stable asthma patients studied here. Viral infection of murine 13 pulmonary epithelial cells strongly reduces their T cell suppressive capacity [7] and our current .
22
In conclusion, we show that human bronchial epithelium exerts potent inhibitory effects hyperresponsiveness (assessed by PC20 AMP<16mg/ml, PC20 methacholine<8mg/ml or PC20 
